Chat with Enda

MSSPT PEPTIDE PEN FOREVER YOUN. R 2450

Epitalon (also known as Epithalon) is a synthetic tetrapeptide with the amino acid sequence Ala-Glu-Asp–Gly (AEDG). It is a mimetic of epithalamin, a natural peptide complex derived from the pineal gland and belongs to the class of Khavinson bioregulator peptides.

Mechanism of Action

Epitalon primarily activates telomerase (via upregulation of telomerase reverse transcriptase gene expression), promoting telomere elongation and delaying replicative senescence in somatic cells. Additional mechanisms include:

Normalization of pineal melatonin secretion and circadian rhythm regulation.

Modulation of neuroendocrine-immune interactions

Enhancement of antioxidant enzyme activity and reduction of oxidative stress

Regulation of gene expression related to aging, DNA repair, and cellular longevity

These effects contribute to cellular rejuvenation, improved endocrine balance, and support for healthy aging processes.

Indications & Usage

Forever Young (Epitalon) is used to support anti-aging, longevity, and cellular health. It is indicated for:

Promotion of telomere maintenance and cellular longevity

Enhancement of sleep quality and circadian rhythm regulation

Support for hormonal balance, immune resilience, and neuroprotection

Assistance in mitigating age-related decline in vitality and recovery

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to Epitalon or any excipient

Active malignancy or history of cancer (theoretical concern regarding cell proliferation) Severe uncontrolled endocrine disorders

Age under 18 years

Pregnancy or breastfeeding

Warnings

Use only under medical supervision.

Not a substitute for standard medical care, lifestyle interventions, or approved therapies for age- related conditions.

Periodic monitoring (e.g., hormonal levels, sleep quality) is advised during long-term use.

Discontinue immediately and seek medical attention if unusual symptoms occur (e.g., severe hormonal changes, sleep disturbances, or signs of allergic reaction).

Dosage & Administration

Subcutaneous injection only.

Recommended Dose: 12 clicks nightly before bed (delivers a full anti-aging dose) Frequency: Nightly administration

Timing: Evening/before bed to align with circadian rhythms

Cycle Protocol: 20 consecutive days on, followed by a 3-month break before repeating the cycle Pen

Duration: Delivers a full 20-day anti-aging cycle per pen

Administration Instructions

Prime pen before first use: Dial to 12 clicks and press until a drop appears at the tip (repeat if needed).

Select dose: Dial to 12 clicks.

Apply to clean skin (commonly abdomen or thigh).

Press and hold for 6 seconds to deliver the dose. 5.Replace cap after use.

Always inspect solution: Do not use if cloudy, discoloured, or containing particles.

Side Effects

Epitalon is generally well tolerated in research settings. Reported reactions are rare and mild/transient, including:

Mild injection–site irritation or redness

Transient headache or light-headedness

Temporary changes in sleep patterns or energy levels during initial cycles

Rare mild gastrointestinal discomfort

If any severe or persistent symptoms occur (e.g., severe headache, hormonal changes, or allergic

signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store in a cool, dry place away from light; replace cap after use.

Ensure solution is clear and properly stored.

Discontinue use if solution appears cloudy or discolored.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

This product is not intended to diagnose, treat, cure, or prevent any disease. Statements have not been evaluated by the FDA, SAHPRA, or other authorities. Always consult a licensed healthcare provider before use, especially if pregnant, breastfeeding, under 18, or managing medical conditions. All products are intended for laboratory and research purposes only; not approved for human consumption, medical, or therapeutic application.

MSSPT PEPTIDE PEN BPC-157 -R 1100

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide with the amino acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val It is a stable gastric pentadecapeptide fragment derived from human gastric juice protein BPC (Body Protection Compound). BPC–157 is highly resistant to enzymatic degradation and exhibits pleiotropic protective and regenerative effects across multiple organ systems.

Mechanism of Action

BPC-157 exerts its effects through multiple overlapping pathways:

Promotion of angiogenesis via upregulation of vascular endothelial growth factor (VEGF) and nitric oxide pathways Modulation of growth factors (e.g., FGF, EGF) and collagen synthesis

Anti-inflammatory action through downregulation of pro–inflammatory cytokines (TNF-a, IL-6) and upregulation of anti- inflammatory mediators

Protection of endothelial integrity and prevention of thrombosis

Acceleration of fibroblast activity, tendon/ligament healing, and extracellular matrix remodelling

Direct cytoprotective effects on gastrointestinal mucosa and other tissues under stress

These mechanisms collectively support accelerated tissue repair, reduced inflammation, and improved functional recovery without significant hormonal or systemic side effects.

Indications & Usage

BPC 157 is used to support tissue healing and recovery. It is indicated for:

Acceleration of healing in muscles, tendons, ligaments, and joints

Reduction of inflammation and associated pain/swelling

Support for recovery from soft–tissue injuries, repetitive strain, or surgical interventions

Maintenance of gastrointestinal mucosal integrity and repair

General regenerative support in musculoskeletal and connective tissue systems

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to BPC-157 or any excipient

Active malignancy or suspected cancer

Severe uncontrolled bleeding disorders or acute thrombosis

Age under 18 years

Warnings

Pregnancy or breastfeeding

Use only under medical supervision.

Not a substitute for standard medical or surgical treatment of injuries, fractures, or inflammatory conditions.

Discontinue immediately and seek medical attention if unusual symptoms occur (e.g., severe swelling, fever, or signs of infection).

Dosage & Administration

Subcutaneous injection only.

Standard Dose Range: 250-500 mcg per injection (0.25-0.5 mg)

250 mcg 6 clicks

500 mcg 12 clicks

Frequency: 1-2 times daily (e.g., morning and evening for active recovery; once daily for maintenance) Timing: Consistent daily timing; inject near target area (if localized effect desired) or abdomen (systemic)

Cycle: 4-6 weeks on for acute protocols; extend to 8 weeks for chronic support, followed by 2-4 weeks off

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial the required number of clicks.

Clean injection site (near injury or abdomen) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

BPC–157 is generally well tolerated. Reported reactions are uncommon and mild/transient, including:

Mild injection-site irritation, redness, or itching

Temporary headache or light-headedness

Rare mild gastrointestinal upset or changes in appetite

Transient fatigue or changes in energy during initial use

If any severe or persistent symptoms occur (e.g., severe pain, swelling, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).

Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

IMPORTANT NOTICE

MSSPT PEPTIDE PEN EASY SLEEP – R 900

Easy Sleep combines two synthetic peptides:

AOD-9604 (Anti-Obesity Drug-9604): A modified fragment of human growth hormone (hGH) comprising amino acids 177-191 with an additional tyrosine residue at the N-terminus. Chemical structure: H-Tyr–Leu-Arg-Ile-Val-Gln-Cys-Arg- Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (disulfide bridge between Cys7 and Cys14).

DSIP (Delta Sleep-Inducing Peptide): A nonapeptide with the sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu. Together, these peptides act synergistically to support sleep architecture, recovery, and metabolic regulation during rest.

Mechanism of Action

AOD-9604 mimics selected lipolytic and anabolic effects of hGH without stimulating IGF-1 production or affecting glucose metabolism. It promotes lipolysis in adipose tissue, enhances fat oxidation, preserves lean mass, and supports tissue repair through modulation of local growth factor pathways and anti-inflammatory signalling. DSIP acts as a neuromodulator and sleep-regulatory peptide. It influences delta–wave (slow-wave) sleep generation, normalizes sleep-wake cycles, reduces stress-induced arousal, modulates GABAergic and serotonergic neurotransmission, and exhibits mild anti-inflammatory and antioxidant properties.

The combination supports deeper restorative sleep, improved nocturnal recovery, reduced nighttime metabolic disturbances, and enhanced overall sleep quality and daytime vitality.

Indications & Usage

Easy Sleep is used to support natural sleep quality and nighttime physiological recovery. It is indicated for:

Promotion of deeper, more restorative sleep stages

Assistance with difficulty falling asleep or maintaining sleep Support for recovery from physical or mental stress during rest

Maintenance of metabolic balance and tissue repair during sleep

General improvement in sleep architecture and daytime energy/resilience

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to AOD-9604, DSIP, or any excipient

Active malignancy or history of hormone–dependent cancer

Severe uncontrolled psychiatric disorders (e.g., severe depression, psychosis)

Untreated sleep apnea or severe respiratory disorders

Age under 18 years

Warnings

Pregnancy or breastfeeding

Use only under medical supervision.

Not a substitute for standard medical treatment of insomnia, sleep apnea, depression, or metabolic disorders.

Avoid operating machinery or driving until effects on alertness are known.

Discontinue immediately and seek medical attention if severe symptoms occur (e.g., chest pain, severe dizziness, breathing difficulties, or mood changes).

Dosage & Administration

Subcutaneous injection only.

Standard Dose: 6 clicks (~250 mcg total actives: ~125 mcg AOD–9604 + 125 mcg DSIP)

Timing: 30-60 minutes before bedtime

Frequency: Once per night

Usage Protocol: Best results occur with consistent nightly use over a 4-6 week cycle

Administration Instructions

Wash hands and prepare a clean surface.

Attach a sterile needle.

Dial 6 clicks.

Clean injection site (abdomen or thigh) with alcohol swab.

Insert needle at 45-90° angle and inject slowly.

Withdraw needle, dispose safely, and cap the pen.

Rotate injection sites to minimize irritation.

Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

Easy Sleep is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching

Transient headache or light–headedness

Temporary vivid dreams or changes in sleep pattern during initial days

Rare mild gastrointestinal discomfort or nausea

Rare restlessness or mild flushing (usually dose-related)

If any severe or persistent symptoms occur (e.g., rapid heartbeat, severe headache, breathing difficulty, or mood changes), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat.

After first use: Same storage conditions.

Keep out of reach of children.

Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user–friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance-providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

MSSPT PEPTIDE PEN MITO BOOST – R 2050

Description

MOTS-C (Mitochondrial Open Reading Frame of the 12S rRNA-c) is a 16–amino–acid mitochondrial–derived peptide (MDP) encoded within the mitochondrial 12S rRNA gene.

Chemical Structure

Sequence: Met-Arg-Trp–Gln–Glu–Met–Gly–Tyr–Ile-Phe-Tyr–Pro–Arg–Lys–Leu-Arg (MRWQEMGYIFYPRKLR)
Molecular weight: ~2,173 Da
It is a linear peptide with no disulfide bonds or post–translational modifications in its native form.

Mechanism of Action

MOTS-C is transcribed and translated within mitochondria, then exported to the cytoplasm and nucleus where it acts as a retrograde signalling molecule. Its primary mechanism involves:

Direct activation of AMP-activated protein kinase (AMPK)
Increased expression of PGC-1a and downstream mitochondrial biogenesis genes
Enhanced fatty acid ẞ-oxidation and glucose uptake
Improvement of insulin sensitivity via reduced inflammatory signalling (↓ NF-kB, ↓ IL-6)
Protection against metabolic stress, oxidative damage, and age-related mitochondrial decline
Modulation of nuclear gene expression related to metabolism, proteostasis, and stress resistance
By acting as a mitokine, MOTS-C coordinates mitochondrial-nuclear communication to optimize energy homeostasis, metabolic flexibility, and cellular resilience.

Indications & Usage

Mito Boost (MOTS-C) is used to support mitochondrial function and metabolic health. It is indicated for:

Enhancement of mitochondrial biogenesis and energy production
Support for fat oxidation, insulin sensitivity, and metabolic efficiency
Assistance during age–related decline in physical performance and recovery
Promotion of endurance, exercise capacity, and cellular resilience under metabolic stress

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to MOTS-C or any excipient
Active malignancy (theoretical concern regarding cellular metabolism enhancement)
Severe uncontrolled liver or kidney disease
Pregnancy or breastfeeding
Age under 18 years

Warnings

Use only under medical supervision with periodic monitoring (e.g., glucose metabolism, liver function, clinical parameters).
Not a substitute for lifestyle interventions or approved therapies for metabolic disorders. High doses may cause transient gastrointestinal discomfort or changes in energy levels.
Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe abdominal pain, allergic reaction, or unexpected neurological changes).

Dosage & Administration

Subcutaneous injection only.
Standard Dose: 5 mg (22 clicks) per injection
(delivers exactly 5 mg based on pen calibration)
Alternative Lower Dose: 3 mg (13 clicks) – for longevity/maintenance or sensitive protocols
Frequency: 2-3 times per week (e.g., Monday/Wednesday/Friday, or spaced around training/recovery days)
Timing: Morning or pre-workout to maximize energy, stamina, and recovery support
Cycle: Typically, 4-12 weeks on, followed by 4 weeks off to maintain efficacy
Optional Loading Phase: First 2-4 weeks: 5 mg 3×/week, then reduce to 2x/week or once weekly for maintenance

Administration Instructions

Wash hands and prepare a clean surface.
Attach a sterile needle.
Dial the required number of clicks (e.g., 22 clicks = 5 mg).
Clean injection site (abdomen or thigh) with alcohol swab. 5.Insert needle at 45-90° angle and inject slowly.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation.
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

MOTS-C is generally well tolerated across preclinical and early human studies. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching
Transient headache or light–headedness
Temporary fatigue or changes in energy levels during initial use
Rare mild gastrointestinal discomfort (nausea, bloating)
If any severe or persistent symptoms occur (e.g., severe headache, abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

MSSPT PEPTIDE PEN MITO REPAIR – R 1950

Description

SS–31 (also known as Elamipretide or Bendavia) is a synthetic tetrapeptide with the sequence D-Arg-Dmt-Lys-Phe-NH2 (where Dmt = 2,6‘-dimethyltyrosine). It is a mitochondria-targeted, cell-permeable peptide designed to concentrate in the inner mitochondrial membrane.

Mechanism of Action

SS-31 selectively binds to cardiolipin, a unique anionic phospholipid almost exclusively found in the inner mitochondrial membrane. This interaction:

Stabilizes cardiolipin structure and prevents peroxidation by reactive oxygen species (ROS)
Protects electron transport chain complexes (especially Complexes I, III, and IV) from oxidative damage
Reduces mitochondrial ROS production and cytochrome c release
Preserves mitochondrial membrane potential (Am) and cristae architecture
Inhibits opening of the mitochondrial permeability transition pore (mPTP)
Improves ATP synthesis efficiency and mitochondrial bioenergetics

By concentrating >1,000-fold in mitochondria (due to its cationic nature and aromatic residues), SS–31 exerts potent localized antioxidant and protective effects without significantly affecting cytosolic redox state.

Indications & Usage

Mito Repair (SS-31) is used to support mitochondrial function and cellular resilience under oxidative stress. It is indicated for:

Protection and restoration of mitochondrial bioenergetics
Support for recovery from metabolic, ischemic, or oxidative stress in tissues
Assistance in age-related or disease-associated mitochondrial dysfunction
General cellular energy, endurance, and tissue repair support

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to SS–31 or any excipient
Active malignancy (theoretical concern regarding cellular metabolism enhancement) Severe uncontrolled hepatic or renal impairment
Pregnancy or breastfeeding
Age under 18 years

Warnings

Use only under medical supervision with periodic monitoring (e.g., clinical symptoms, metabolic parameters).
Not a substitute for standard medical treatment of mitochondrial disorders, ischemia, or chronic diseases.
Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe fatigue, chest pain, shortness of breath, or signs of allergic reaction).

Dosage & Administration

Subcutaneous injection only.
Standard Dose: 5 mg (22 clicks) per injection
(delivers exactly 5 mg based on pen calibration)
Alternative Lower Dose: 3 mg (13 clicks)– for longevity/maintenance or sensitive protocols
Frequency: 2-3 times per week (e.g., Monday/Wednesday/Friday, or spaced around training/recovery days)
Timing: Morning or pre-activity to maximize energy, stamina, and recovery support
Cycle: Typically, 4-12 weeks on, followed by 4 weeks off to maintain efficacy
Optional Loading Phase: First 2-4 weeks: 5 mg 3x/week, then reduce to 2x/week or once weekly for maintenance

Administration Instructions

Wash hands and prepare a clean surface.
Attach a sterile needle.
Dial the required number of clicks (e.g., 22 clicks = 5 mg).
Clean injection site (abdomen or thigh) with alcohol swab.
Insert needle at 45-90° angle and inject slowly.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation.
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

SS-31 is generally well tolerated across clinical and preclinical studies. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching
Transient headache or light-headedness
Temporary fatigue or changes in energy levels during initial use
Rare mild gastrointestinal discomfort
If any severe or persistent symptoms occur (e.g., severe headache, chest pain, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F). Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

MSSPT PEPTIDE PEN NAD + – R 1500

Description

Nicotinamide Adenine Dinucleotide (NAD+) is a vital coenzyme found in all living cells. It consists of two nucleotides joined by their phosphate groups: one containing adenine and the other nicotinamide. The full chemical structure is: Nicotinamide-ribose-P-P-ribose-adenine (with the nicotinamide ring capable of accepting/donating a hydride ion, allowing conversion between NAD* and NADH). NAD+ exists in oxidized (NAD) and reduced (NADH) forms and is central to cellular energy metabolism and redox homeostasis.

Mechanism of Action

NAD+ serves as a co-substrate for multiple critical enzyme families:

Sirtuins (SIRT1-7) → epigenetic regulation, DNA repair, mitochondrial biogenesis, inflammation suppression, and longevity pathways
PARPS (Poly-ADP-ribose polymerases) → DNA damage detection and repair, genomic stability
CD38/CD157 → calcium mobilization, immune cell signalling, and NAD+ consumption

Exogenous NAD+ administration rapidly elevates intracellular and extracellular NAD+ pools, restoring age- or stress- related decline. This activates sirtuins and PARPs, enhances mitochondrial oxidative phosphorylation, increases ATP production, improves metabolic flexibility, reduces oxidative stress, supports cellular repair mechanisms, and promotes resilience against metabolic and inflammatory insults.

Indications & Usage

NAD+ is used to support cellular energy metabolism, mitochondrial function, and age-related physiological processes. It is indicated for:

Restoration of NAD+ levels and cellular energy production
Enhancement of mitochondrial efficiency, metabolic rate, and insulin sensitivity Support during age-related decline in vitality, endurance, and recovery capacity Assistance in cellular repair, resilience, and overall metabolic/anti-aging pathways

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to NAD+ or any excipient
Active malignancy (theoretical concern regarding enhanced cellular metabolism) Severe uncontrolled liver or kidney disease
Pregnancy or breastfeeding
Age under 18 years

Warnings

Use only under medical supervision with periodic monitoring (liver function, glucose metabolism, and clinical parameters).
Not a substitute for lifestyle interventions or approved therapies for metabolic or age-related conditions.
High doses may cause transient flushing, gastrointestinal discomfort, or changes in energy levels.
Discontinue immediately and seek medical attention if severe symptoms occur (e.g., severe abdominal pain, allergic reaction, or unexpected neurological changes).

Dosage & Administration

Subcutaneous injection only.
Standard/maintenance dose: 50 mg per injection
Clicks per dose: 12 clicks (50 ÷ 4.167≈ 12)
Higher/performance dose: 75-100 mg
- 75 mg: ~18 clicks (75 ÷ 4.167≈≈ 18)
- 100 mg: 24 clicks (100 ÷ 4.167~24)
Frequency:
- Loading phase (first 1-2 weeks): Daily or 5-7x/week at 50 mg
- Maintenance: 2-3 times per week or every other day
Timing: Morning or pre-activity for energy/performance support; evening for recovery/sleep quality support
Cycle length: 4-12 weeks on (often 30-90 days for cellular/metabolic protocols), followed by 4 weeks off

Administration Instructions

Wash hands and prepare a clean surface.
Attach a sterile needle.
Dial the required number of clicks.
Clean injection site (abdomen or thigh) with alcohol swab.
Insert needle at 45-90° angle and inject slowly.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation.
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

NAD+ administration is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching
Transient headache, light-headedness, or flushing
Temporary gastrointestinal discomfort (nausea, bloating)
Rare fatigue or changes in energy levels during initial use
Very rare hypersensitivity reactions
If any severe or persistent symptoms occur (e.g., severe headache, abdominal pain, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C/77-86°F).
Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

Peptide Pen Testagen (Bioregulator peptide) – R 1250

Description

Testagen (H-Lys-Glu-Asp-Gly-OH) is a synthetic tetrapeptide bioregulator. It consists of a short–chain amino acid sequence that acts as a highly specific cellular signal, selectively activating or silencing target genes to promote tissue repair, regulate physiological processes, and support cellular homeostasis. Developed from decades of research into Khavinson peptides, Testagen is designed to target testicular and reproductive tissues at the epigenetic level, helping to restore and maintain optimal function.

Indications & Usage

Testagen is used to support prostate health, hormonal balance, and overall male vitality. It aids in tissue repair, reduces inflammation, and promotes regenerative processes in the reproductive and endocrine systems. It is commonly applied for:

General prostate support and maintenance
Joint and connective tissue wellness
Intensive recovery and targeted regenerative benefits

Dosage & Administration

Subcutaneous injection only.
Low Dose (0.5 mg): 6 clicks daily for maintenance and general prostate support (yields 40 doses)
Moderate Dose (1 mg): 12 clicks daily for joint strain relief and moderate wellness (yields 20 doses)
High Dose (2 mg): 24 clicks daily- for intensive recovery and targeted prostate benefits (yields 10 doses)
Frequency: Once daily
Timing: Morning on an empty stomach or as directed by your healthcare provider

Administration Instructions

Attach a sterile needle.
Dial your dose (e.g., 6 clicks = 0.5 mg).
Clean injection site (abdomen or thigh recommended).
Inject subcutaneously.
Cap pen and store properly.
Use consistently and pair with healthy diet, exercise, and lifestyle habits.
Always inspect solution before use: Do not use if cloudy, discoloured, or containing particles.

Contraindications & Warnings

Not for individuals under 18 years of age.
Not for pregnant or breastfeeding women.
Avoid if you have known allergies to any components or serious medical conditions (including prostate disorders, hormonal imbalances, or autoimmune issues) unless cleared by a doctor.
Consult a licensed healthcare provider before use.

Side Effects

Potential adverse reactions may include:

Mild injection site irritation, redness, or swelling
Headache or mild nausea
Temporary changes in energy or sleep patterns
Rare digestive discomfort
Monitor for any unexpected responses.
Discontinue use and seek medical guidance if side effects persist or worsen.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C/77-86°F). Keep pen capped and clean.
Protect from light and heat.
After use: Same conditions.
Out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for reliable delivery in challenging environments.

Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user- friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. No mixing, no guesswork, and reliable performance in every dose, wherever you are.

IMPORTANT NOTICE

MSSPT PEPTIDE PEN THYMOGEN – R 1250

Peptide Pen Thymogen

Description

Thymogen is a synthetic dipeptide with the chemical structure H-Glu-Trp-OH (L-Glutamyl-L-Tryptophan). It is a short- chain, tissue-specific bioregulator peptide originally developed in the former Soviet Union as part of the Khavinson peptide series. Thymogen mimics natural thymic factors and acts as a highly selective immunomodulatory signal.

Mechanism of Action

Thymogen binds to specific receptors on immune cells (primarily T-lymphocytes, NK cells, and monocytes/macrophages) and modulates intracellular signalling pathways. It normalizes gene expression patterns involved in:

T-cell differentiation and maturation
Cytokine production (e.g., IL-2, IFN-Y)
Antioxidant enzyme activity (superoxide dismutase, catalase)
Apoptosis regulation and cell survival
Restoration of thymic microenvironment function

These effects result in balanced immune homeostasis, enhanced cellular immunity, reduced chronic inflammation, and accelerated recovery of immune competence after stress, infection, or age related decline.

Indications & Usage

Thymogen is used to support immune system function and resilience. It is indicated for:

Maintenance and restoration of immune competence
Assistance during periods of increased immune demand (e.g., recovery from illness, stress, or environmental exposure)
Support for age-related decline in thymic activity and T-cell function
General immune modulation and anti-aging support at the level of the immune system

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to any component of the formulation
Active autoimmune disease in acute phase
Uncontrolled malignancy or immunosuppressive therapy
Age under 18 years
Pregnancy or breastfeeding

Warnings

Use only under medical supervision.
Not a substitute for standard medical treatment of infections, autoimmune disorders, or immunodeficiency.
Monitor for signs of immune overstimulation (e.g., fever, rash, joint pain) during initial use.
Discontinue immediately and seek medical attention if unusual or severe symptoms occur.

Dosage & Administration

Subcutaneous injection only.

Low Dose (0.5 mg): 6 clicks daily- maintenance and general immune support (yields 40 doses)
Moderate Dose (1 mg): 12 clicks daily- moderate immune modulation and recovery support (yields 20 doses)
High Dose (2 mg): 24 clicks daily intensive immune restoration and targeted support (yields 10 doses)
Frequency: Once daily
Timing: Morning on an empty stomach or as directed by your healthcare provider

Administration Instructions

Wash hands and prepare a clean surface.
Attach a sterile needle.
Dial the required number of clicks.
Clean injection site (abdomen or upper thigh) with alcohol swab.
Insert needle at 45-90° angle and inject slowly.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation.
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

Thymogen is generally well tolerated. Reported reactions are rare and mild, including:

Transient injection-site redness, itching, or mild swelling
Headache or light-headedness (usually resolves quickly)
Temporary fatigue or changes in energy levels during initial days
Rare mild flu-like symptoms (myalgia, low grade fever) during first week
If any severe or persistent symptoms occur, discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).
Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

MSSPT

Peptide Pen Prostamax – R 1250

Description

Prostamax is a short-chain, tissue-specific bioregulator peptide designed to support the physiological function of prostate tissue. It belongs to the class of peptide bioregulators developed to regulate cellular signalling and gene expression within targeted organs. Prostamax mimics naturally occurring regulatory peptides found in prostate tissue and acts as a selective biological signal that supports cellular balance and tissue maintenance.

Mechanism of Action

Prostamax interacts with intracellular regulatory pathways within prostate epithelial and stromal cells and modulates gene expression patterns involved in:

Cellular repair and regeneration of prostate tissue
Regulation of local inflammatory signalling pathways
Normalization of prostate secretory activity
Support of microcirculation and tissue oxygenation
Maintenance of normal cellular metabolism and protein synthesis

These effects contribute to balanced prostate cellular homeostasis, improved tissue resilience, reduced cellular stress, and support of normal prostate function during aging or physiological strain.

Indications & Usage

Prostamax is used to support prostate tissue function and cellular regulation. It is indicated for:

Maintenance of normal prostate tissue structure and function
Support during age–related decline in prostate cellular activity
Assistance during periods of increased physiological stress affecting prostate tissue
Support for healthy microcirculation and tissue metabolism in the prostate
General regenerative and anti-aging support at the level of prostate cellular regulation

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to any component of the formulation
Active prostate malignancy without physician supervision
Uncontrolled systemic illness
Age under 18 years
Pregnancy or breastfeeding

Warnings

Use only under medical supervision.
Not a substitute for standard medical evaluation of prostate disorders.
Monitor for unusual urinary or systemic symptoms during initial use.
Discontinue immediately and seek medical attention if unusual or severe symptoms occur.

Dosage & Administration

Subcutaneous injection only.
Low Dose (0.5 mg): 6 clicks daily maintenance and general prostate support (yields 40 doses)
Moderate Dose (1 mg): 12 clicks daily- targeted prostate regulation (yields 20 doses)
High Dose (2 mg): 24 clicks daily-intensive cellular support (yields 10 doses)
Frequency: Once daily
Timing: Morning on an empty stomach or as directed by your healthcare provider

Administration Instructions

Wash hands and prepare a clean surface.
Attach a sterile needle.
Dial the required number of clicks.
Clean injection site (abdomen or upper thigh) with alcohol swab.
Insert needle at 45-90° angle and inject slowly.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation.
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

Prostamax is generally well tolerated. Reported reactions are rare and mild, including:

Transient injection–site redness, itching, or mild swelling
Headache or light-headedness (usually resolves quickly)
Temporary fatigue or changes in energy levels during initial days
Rare mild flu-like symptoms (myalgia, low-grade fever) during first week
If any severe or persistent symptoms occur, discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).
Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance- providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE

MSSPT PEPTIDE PEN WOLVERINE – R 1600

Description

Wolverine combines two highly regarded synthetic peptides with complementary tissue- protective and regenerative properties:

BPC-157 (Body Protection Compound–157): A synthetic pentadecapeptide derived from a protective gastric protein. Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV).
TB–500 (Thymosin Beta-4 active fragment): A synthetic version of the active domain of Thymosin Beta–4, a 43-amino- acid actin-sequestering protein. Key active sequence: Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln (Ac-LKKTETQ).

Mechanism of Action

BPC-157 exerts broad cytoprotective, angiogenic, and anti-inflammatory effects. It upregulates VEGF and nitric oxide pathways to promote angiogenesis, enhances fibroblast migration and collagen deposition, modulates growth factors (FGF, EGF), protects endothelial integrity, counteracts NSAID-induced damage, and accelerates tendon, ligament, muscle, and gastrointestinal healing via multiple overlapping pathways.
TB-500 promotes actin sequestration and polymerization, facilitating cell migration, angiogenesis, wound healing, and tissue repair. It reduces inflammation, inhibits apoptosis, enhances extracellular matrix remodelling, and supports regeneration in muscle, tendon, ligament, skin, and corneal tissues.

The combination synergistically accelerates soft-tissue repair, reduces inflammation, improves vascularization, enhances extracellular matrix quality, and supports rapid functional recovery across musculoskeletal, connective, and dermal systems.

Indications & Usage

Wolverine is used to support accelerated tissue healing and regenerative processes. It is indicated for:

Promotion of healing in muscles, tendons, ligaments, and joints
Reduction of inflammation and support for recovery from soft-tissue injuries
Assistance in recovery from repetitive strain, overuse, or surgical interventions
Maintenance of connective tissue integrity and anti-inflammatory support

Contraindications & Warnings

Do not use if you have:

Known hypersensitivity to BPC-157, TB-500, or any excipient
Active malignancy or history of cancer (theoretical concern regarding pro-angiogenic properties)
Severe uncontrolled bleeding disorders or acute thrombosis
Pregnancy or breastfeeding
Age under 18 years

Warnings

Use only under medical supervision.
Not a substitute for standard medical or surgical treatment of injuries, fractures, or inflammatory conditions.
Discontinue immediately and seek medical attention if unusual symptoms occur (e.g., severe swelling, fever, or signs of infection/allergic reaction).
Avoid concurrent use with other strong pro–angiogenic agents unless under specialist guidance.

Dosage & Administration

Subcutaneous injection only.
Standard Dose: 6 clicks per dose (~250 mcg total actives: ~125 mcg BPC-157 + 125 mcg TB-500)
Timing: 30-60 minutes before bedtime or as directed by your healthcare provider
Frequency: Once per night
Usage Protocol: Best results occur with consistent nightly use over a 4-6 week cycle

Administration Instructions

Wash hands and prepare a clean surface.
Attach a sterile needle.
Dial 6 clicks.
Clean injection site (abdomen or near target area) with alcohol swab.
Insert needle at 45-90° angle and inject slowly.
Withdraw needle, dispose safely, and cap the pen.
Rotate injection sites to minimize irritation (near injury site if localized effect desired).
Always inspect solution before use: Do not inject if cloudy, discoloured, or containing particles.

Side Effects

Wolverine is generally well tolerated. Reported reactions are uncommon and usually mild/transient, including:

Mild injection-site irritation, redness, or itching
Transient headache or light-headedness
Temporary fatigue or changes in energy levels during initial days
Rare mild gastrointestinal discomfort
If any severe or persistent symptoms occur (e.g., severe pain, swelling, or allergic signs), discontinue use and contact your healthcare provider immediately.

Storage & Handling

Store either in refrigerator (fridge); never freeze or in a cool dry place (≤25-30°C / 77-86°F).
Keep pen capped and protected from light and heat.
After first use: Same storage conditions.
Keep out of reach of children.
Discard if expired or solution appears abnormal.

Peptide Pen formulations set the standard for research peptide delivery in challenging environments. Powered by exclusive MSSPT, each pen combines buffers, antioxidants, and proprietary agents in a compact, user-friendly injector, delivering strict control over pH, light, oxygen, oxidative factors, and moisture even under South Africa’s subtropical variability or the UAE’s extreme desert heat and humidity. This proprietary technology positions Peptide Pen as the premier choice for researchers in these regions: no mixing, no guesswork, and reliable, high-fidelity results despite demanding protocols and climates. Every Peptide Pen is built for exceptional durability, reliability, and performance, providing precision molecular stabilization in every dose, wherever your research takes you.

IMPORTANT NOTICE